Statistics from Altmetric.com
Does motivational enhancement therapy (MET) with or without cognitive behavioural lead to improved glycaemic control in people with type I diabetes?
344 adults (18–65 years) with type 1 diabetes for a minimum duration of 2 years, defined as onset at younger than 35 years of age, a current glycated haemoglobin (HbA1C) value between 8.2% and 15.0% and onset of insulin therapy within 6 months of diagnosis or ketones in the urine. The patients had diabetes for a median of 18 years.
London and Greater Manchester; September 2003 and August 2005.
MET or a combination of MET and cognitive–behaviour therapy (CBT), both groups also had usual diabetes care. These groups were compared to usual care alone. The interventions were delivered by nurse therapists and were developed by the researchers.
Primary outcome was HbAlc at 12 months from randomisation. Secondary outcomes included 1 year costs assessed by the Client Service Receipt Inventory at baseline, 6 months and 12 months and quality-adjusted life years (QALYs) at baseline and 12 months.
Randomised controlled trial.
Single blind; …
Sources of funding National Institute for Health Research.
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.